Trusting god and medicine: Spirituality in advanced cancer patients volunteering for clinical trials of experimental agents

被引:45
作者
Daugherty, CK
Fitchett, G
Murphy, PE
Peterman, AH
Banik, DM
Hlubocky, F
Tartaro, J
机构
[1] Rush Univ, Ctr Med, Dept Relig Studies Hlth & Human Values, Chicago, IL 60612 USA
[2] Univ Chicago, Ctr Med, Hematol Oncol Sect, Chicago, IL USA
[3] Northwestern Univ, Feinburg Sch Med, Evanston, IL USA
[4] Univ New England, Coll Osteopath Med, Biddeford, ME USA
[5] Arizona State Univ, Dept Psychol, Tempe, AZ USA
关键词
D O I
10.1002/pon.829
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study was to examine the role of spirituality in terminally ill cancer patients who volunteer for clinical trials of experimental agents. Information about spirituality (FACIT-Sp), quality of life (FACT-G), awareness of prognosis, and decision-making preferences was obtained from 162 advanced cancer patients who volunteered for phase I trials. In a multivariable model, phase I patients had slightly higher levels of spirituality (p < 0.001) than a group of 156 advanced cancer patients who were not participants in phase I trials. For the phase I patients, spirituality was positively associated with quality of life (Spearman rho = 0.36, p < 0.001). There was little association between either spirituality or religious problem-solving style and phase I patients' awareness of their prognosis or decision-making preferences. One phase I patient who said, 'I put faith in doctors and God,' expressed these patients' willingness to trust both God and medicine. Copyright (C) 2004 John Wiley Sons, Ltd.
引用
收藏
页码:135 / 146
页数:12
相关论文
共 75 条
[11]   Prognostic awareness and the terminally ill [J].
Chochinov, HM ;
Tataryn, DJ ;
Wilson, KG ;
Enns, M ;
Lander, S .
PSYCHOSOMATICS, 2000, 41 (06) :500-504
[12]  
Christakis Nicholas, 1999, DEATH FORETOLD PROPH
[13]   Relationship of psychosocial and background variables to older adults' end-of-life decisions [J].
Cicirelli, VG .
PSYCHOLOGY AND AGING, 1997, 12 (01) :72-83
[14]   Hastening death: A comparison of two end-of-life decisions [J].
Cicirelli, VG ;
MacLean, AP ;
Cox, LS .
DEATH STUDIES, 2000, 24 (05) :401-419
[15]  
Costantini-Ferrando MF, 1998, JAMA-J AM MED ASSOC, V280, P1403, DOI 10.1001/jama.280.16.1403
[16]  
Cotton SP, 1999, PSYCHO-ONCOL, V8, P429, DOI 10.1002/(SICI)1099-1611(199909/10)8:5<429::AID-PON420>3.0.CO
[17]  
2-P
[18]   PERCEPTIONS OF CANCER-PATIENTS AND THEIR PHYSICIANS INVOLVED IN PHASE-I TRIALS [J].
DAUGHERTY, C ;
RATAIN, MJ ;
GROCHOWSKI, E ;
STOCKING, C ;
KODISH, E ;
MICK, R ;
SIEGLER, M .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) :1062-1072
[19]  
Daugherty C K, 2000, IRB, V22, P6, DOI 10.2307/3564113
[20]   Learning from our patients: One participant's impact on clinical trial research and informed consent [J].
Daugherty, CK ;
Siegler, M ;
Ratain, MJ ;
Zimmer, G .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (11) :892-897